Sections
| Title | Starting Page | Number of Pages |
|---|
| Cover Page | 1 | 1 |
| List of Contents and Tables | 2 | 1 |
| MARKET INDICATORS | 2 | 1 |
| Analgesics in Taiwan - Category Analysis | 2 | 1 |
| PROSPECTS and OPPORTUNITIES | 2 | 1 |
| CATEGORY DATA | 2 | 1 |
| Table/Chart: 4 | 2 | 1 |
| Table/Chart: Tabular Data Analysis | 2 | 1 |
| CONSUMER HEALTH IN TAIWAN | 3 | 1 |
| PROSPECTS and OPPORTUNITIES | 3 | 1 |
| Table/Chart: 24 | 3 | 1 |
| Table/Chart: Tabular Data Analysis | 3 | 1 |
| Table/Chart: CATEGORY DATA | 3 | 1 |
| CONSUMER HEALTH IN TAIWAN | 4 | 1 |
| CATEGORY DATA | 4 | 1 |
| Eye Care in Taiwan - Category Analysis | 4 | 1 |
| KEY DATA FINDINGS | 4 | 1 |
| PROSPECTS and OPPORTUNITIES | 4 | 1 |
| Table/Chart: 40 | 4 | 1 |
| Table/Chart: Tabular Data Analysis | 4 | 1 |
| CONSUMER HEALTH IN TAIWAN | 5 | 1 |
| Table/Chart: CATEGORY DATA | 5 | 1 |
| Table/Chart: Tabular Data Analysis | 5 | 1 |
| PROSPECTS and OPPORTUNITIES | 6 | 1 |
| CATEGORY DATA | 6 | 1 |
| KEY DATA FINDINGS | 6 | 1 |
| Table/Chart: 73 | 6 | 1 |
| Table/Chart: Tabular Data Analysis | 6 | 1 |
| CONSUMER HEALTH IN TAIWAN | 7 | 1 |
| Table/Chart: Tabular Data Analysis | 7 | 1 |
| CONSUMER HEALTH IN TAIWAN | 8 | 1 |
| Table/Chart: 111 | 8 | 1 |
| Table/Chart: Tabular Data Analysis | 8 | 1 |
| Consumer Health in Taiwan - Industry Overview | 9 | 1 |
| EXECUTIVE SUMMARY | 9 | 1 |
| Key trends in 2025 | 9 | 1 |
| CONSUMER HEALTH IN TAIWAN | 10 | 1 |
| CONSUMER HEALTH IN TAIWAN | 11 | 1 |
| Channel developments | 11 | 1 |
| What next for consumer health? | 11 | 1 |
| CONSUMER HEALTH IN TAIWAN | 12 | 1 |
| MARKET INDICATORS | 12 | 1 |
| MARKET DATA | 12 | 1 |
| Table/Chart: Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025 | 12 | 1 |
| Table/Chart: Tabular Data Analysis | 12 | 1 |
| Table/Chart: Table 2 Life Expectancy at Birth 2020-2025 | 12 | 1 |
| Table/Chart: Table 3 Sales of Consumer Health by Category: Value 2020-2025 | 12 | 1 |
| CONSUMER HEALTH IN TAIWAN | 13 | 1 |
| Table 4 Sales of Consumer Health by Category: % Value Growth 2020-2025 | 13 | 1 |
| Table/Chart: Tabular Data Analysis | 13 | 1 |
| Table/Chart: % current value growth | 13 | 1 |
| Table/Chart: Table 5 NBO Company Shares of Consumer Health: % Value 2021-2025 | 13 | 1 |
| CONSUMER HEALTH IN TAIWAN | 14 | 1 |
| Table/Chart: Tabular Data Analysis | 14 | 1 |
| Table/Chart: Table 6 LBN Brand Shares of Consumer Health: % Value 2022-2025 | 14 | 1 |
| CONSUMER HEALTH IN TAIWAN | 15 | 1 |
| Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2020-2025 | 15 | 1 |
| Table 8 Distribution of Consumer Health by Format: % Value 2020-2025 | 15 | 1 |
| Table/Chart: Tabular Data Analysis | 15 | 1 |
| Table/Chart: % retail value rsp | 15 | 1 |
| CONSUMER HEALTH IN TAIWAN | 16 | 1 |
| Table 9 Distribution of Consumer Health by Format and Category: % Value 2025 | 16 | 1 |
| Table/Chart: Tabular Data Analysis | 16 | 1 |
| Table/Chart: % retail value rsp | 16 | 1 |
| CONSUMER HEALTH IN TAIWAN | 17 | 1 |
| Table/Chart: Tabular Data Analysis | 17 | 1 |
| CONSUMER HEALTH IN TAIWAN | 18 | 1 |
| Table 10 Forecast Sales of Consumer Health by Category: Value 2025-2030 | 18 | 1 |
| Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030 | 18 | 1 |
| Table/Chart: Tabular Data Analysis | 18 | 1 |
| Table/Chart: TWD million | 18 | 1 |
| Table/Chart: % constant value growth | 18 | 1 |
| APPENDIX | 19 | 1 |
| Otc registration and classification | 19 | 1 |
| CONSUMER HEALTH IN TAIWAN | 20 | 1 |
| Vitamins and dietary supplements registration and classification | 20 | 1 |
| Disclosure | 21 | 1 |
| Disclosure | 22 | 1 |
| Graph - Sources used during the research included the following: | 22 | 1 |
| Table/Chart: Sources used during the research included the following: | 22 | 1 |
| Table/Chart: Tabular Data Analysis | 22 | 1 |
| Disclosure | 23 | 1 |
| Graph - CONSUMER HEALTH IN TAIWAN | 23 | 1 |
| Graph - Source: Euromonitor International | 23 | 1 |
| Disclosure | 24 | 1 |
| Disclosure | 25 | 1 |
| Disclosure | 26 | 1 |
| Disclosure | 27 | 1 |
| Table/Chart: TWD million | 27 | 1 |
| Table/Chart: Tabular Data Analysis | 27 | 1 |
| Disclosure | 28 | 1 |
| Table/Chart: Tabular Data Analysis | 28 | 1 |
| Table/Chart: Table 14 NBO Company Shares of Analgesics: % Value 2021-2025 | 28 | 1 |
| Disclosure | 29 | 1 |
| Table/Chart: Tabular Data Analysis | 29 | 1 |
| Table/Chart: Table 15 LBN Brand Shares of Analgesics: % Value 2022-2025 | 29 | 1 |
| Disclosure | 30 | 1 |
| Table/Chart: Tabular Data Analysis | 30 | 1 |
| Table/Chart: TWD million | 30 | 1 |
| Disclosure | 31 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 31 | 1 |
| Table/Chart: Tabular Data Analysis | 31 | 1 |
| Table/Chart: Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2025-2030 | 31 | 1 |
| Disclosure | 32 | 1 |
| Disclosure | 33 | 1 |
| Disclosure | 34 | 1 |
| Disclosure | 35 | 1 |
| Table/Chart: TWD million | 35 | 1 |
| Table/Chart: Tabular Data Analysis | 35 | 1 |
| Table/Chart: % current value growth | 35 | 1 |
| Table/Chart: Table 20 NBO Company Shares of Sleep Aids: % Value 2021-2025 | 35 | 1 |
| Table/Chart: Table 21 LBN Brand Shares of Sleep Aids: % Value 2022-2025 | 35 | 1 |
| Disclosure | 36 | 1 |
| Graph - Table 23 Forecast Sales of Sleep Aids: % Value Growth 2025-2030 | 36 | 1 |
| Table/Chart: TWD million | 36 | 1 |
| Table/Chart: Tabular Data Analysis | 36 | 1 |
| Table/Chart: Table 23 Forecast Sales of Sleep Aids: % Value Growth 2025-2030 | 36 | 1 |
| Disclosure | 37 | 1 |
| Disclosure | 38 | 1 |
| Disclosure | 39 | 1 |
| Disclosure | 40 | 1 |
| Table/Chart: Table 24 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025 | 40 | 1 |
| Table/Chart: Tabular Data Analysis | 40 | 1 |
| Disclosure | 41 | 1 |
| Table/Chart: Tabular Data Analysis | 41 | 1 |
| Table/Chart: Table 26 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021- 2025 | 41 | 1 |
| Disclosure | 42 | 1 |
| Table/Chart: Tabular Data Analysis | 42 | 1 |
| Table/Chart: Table 27 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2022-2025 | 42 | 1 |
| Disclosure | 43 | 1 |
| Table/Chart: TWD million | 43 | 1 |
| Table/Chart: Tabular Data Analysis | 43 | 1 |
| Table/Chart: % constant value growth | 43 | 1 |
| Disclosure | 44 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 44 | 1 |
| Table/Chart: Tabular Data Analysis | 44 | 1 |
| Disclosure | 45 | 1 |
| Disclosure | 46 | 1 |
| Disclosure | 47 | 1 |
| Disclosure | 48 | 1 |
| Table/Chart: TWD million | 48 | 1 |
| Table/Chart: Tabular Data Analysis | 48 | 1 |
| Disclosure | 49 | 1 |
| Table/Chart: Tabular Data Analysis | 49 | 1 |
| Table/Chart: Table 32 NBO Company Shares of Dermatologicals: % Value 2021-2025 | 49 | 1 |
| Disclosure | 50 | 1 |
| Table/Chart: Tabular Data Analysis | 50 | 1 |
| Disclosure | 51 | 1 |
| Table/Chart: Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2022-2025 | 51 | 1 |
| Table/Chart: Tabular Data Analysis | 51 | 1 |
| Table/Chart: TWD million | 51 | 1 |
| Table/Chart: % constant value growth | 51 | 1 |
| Disclosure | 52 | 1 |
| Graph - CONSUMER HEALTH IN TAIWAN | 52 | 1 |
| Disclosure | 53 | 1 |
| Disclosure | 54 | 1 |
| Disclosure | 55 | 1 |
| Table/Chart: Table 37 Sales of Digestive Remedies by Category: Value 2020-2025 | 55 | 1 |
| Table/Chart: Tabular Data Analysis | 55 | 1 |
| Disclosure | 56 | 1 |
| Table/Chart: Tabular Data Analysis | 56 | 1 |
| Table/Chart: % current value growth | 56 | 1 |
| Table/Chart: Table 39 NBO Company Shares of Digestive Remedies: % Value 2021-2025 | 56 | 1 |
| Disclosure | 57 | 1 |
| Table/Chart: Tabular Data Analysis | 57 | 1 |
| Table/Chart: Table 40 LBN Brand Shares of Digestive Remedies: % Value 2022-2025 | 57 | 1 |
| Disclosure | 58 | 1 |
| Table/Chart: Tabular Data Analysis | 58 | 1 |
| Table/Chart: TWD million | 58 | 1 |
| Table/Chart: % constant value growth | 58 | 1 |
| Disclosure | 59 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 59 | 1 |
| Table/Chart: Tabular Data Analysis | 59 | 1 |
| Disclosure | 60 | 1 |
| Disclosure | 61 | 1 |
| Disclosure | 62 | 1 |
| Disclosure | 63 | 1 |
| Table/Chart: TWD million | 63 | 1 |
| Table/Chart: Tabular Data Analysis | 63 | 1 |
| Table/Chart: % current value growth | 63 | 1 |
| Table/Chart: Table 45 NBO Company Shares of Eye Care: % Value 2021-2025 | 63 | 1 |
| Disclosure | 64 | 1 |
| Table/Chart: Tabular Data Analysis | 64 | 1 |
| Table/Chart: Table 46 LBN Brand Shares of Eye Care: % Value 2022-2025 | 64 | 1 |
| Table/Chart: Table 47 Forecast Sales of Eye Care by Category: Value 2025-2030 | 64 | 1 |
| Disclosure | 65 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 65 | 1 |
| Table/Chart: Tabular Data Analysis | 65 | 1 |
| Disclosure | 66 | 1 |
| Graph - Declining smoking rates and public policy drive growth of nrt smoking cessation aids in taiwan | 66 | 1 |
| Disclosure | 67 | 1 |
| Disclosure | 68 | 1 |
| Disclosure | 69 | 1 |
| Disclosure | 70 | 1 |
| Table/Chart: Tabular Data Analysis | 70 | 1 |
| Table/Chart: TWD million | 70 | 1 |
| Table/Chart: % current value growth | 70 | 1 |
| Table/Chart: Table 52 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2021-2025 | 70 | 1 |
| Disclosure | 71 | 1 |
| Table/Chart: Table 53 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2022-2025 | 71 | 1 |
| Table/Chart: Tabular Data Analysis | 71 | 1 |
| Table/Chart: TWD million | 71 | 1 |
| Table/Chart: Table 55 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2025-2030 | 71 | 1 |
| Disclosure | 72 | 1 |
| Disclosure | 73 | 1 |
| Disclosure | 74 | 1 |
| Disclosure | 75 | 1 |
| Table/Chart: TWD million | 75 | 1 |
| Table/Chart: Tabular Data Analysis | 75 | 1 |
| Table/Chart: % current value growth | 75 | 1 |
| Table/Chart: Table 58 NBO Company Shares of Wound Care: % Value 2021-2025 | 75 | 1 |
| Disclosure | 76 | 1 |
| Table/Chart: Tabular Data Analysis | 76 | 1 |
| Table/Chart: Table 59 LBN Brand Shares of Wound Care: % Value 2022-2025 | 76 | 1 |
| Table/Chart: TWD million | 76 | 1 |
| Table/Chart: % constant value growth | 76 | 1 |
| Disclosure | 77 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 77 | 1 |
| Disclosure | 78 | 1 |
| Disclosure | 79 | 1 |
| Disclosure | 80 | 1 |
| Disclosure | 81 | 1 |
| Table/Chart: TWD million | 81 | 1 |
| Table/Chart: Tabular Data Analysis | 81 | 1 |
| Table/Chart: % current value growth | 81 | 1 |
| Disclosure | 82 | 1 |
| Table/Chart: Table 64 NBO Company Shares of Sports Nutrition: % Value 2021-2025 | 82 | 1 |
| Table/Chart: Tabular Data Analysis | 82 | 1 |
| Table/Chart: Table 65 LBN Brand Shares of Sports Nutrition: % Value 2022-2025 | 82 | 1 |
| Disclosure | 83 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 83 | 1 |
| Table/Chart: TWD million | 83 | 1 |
| Table/Chart: Tabular Data Analysis | 83 | 1 |
| Table/Chart: % constant value growth | 83 | 1 |
| Disclosure | 84 | 1 |
| Disclosure | 85 | 1 |
| Disclosure | 86 | 1 |
| Disclosure | 87 | 1 |
| Disclosure | 88 | 1 |
| Table/Chart: Table 68 Sales of Dietary Supplements by Category: Value 2020-2025 | 88 | 1 |
| Table/Chart: Tabular Data Analysis | 88 | 1 |
| Disclosure | 89 | 1 |
| Table/Chart: Tabular Data Analysis | 89 | 1 |
| Table/Chart: % current value growth | 89 | 1 |
| Disclosure | 90 | 1 |
| Table/Chart: % retail value rsp | 90 | 1 |
| Table/Chart: Tabular Data Analysis | 90 | 1 |
| Table/Chart: Table 71 NBO Company Shares of Dietary Supplements: % Value 2021-2025 | 90 | 1 |
| Disclosure | 91 | 1 |
| Graph - Table 72 LBN Brand Shares of Dietary Supplements: % Value 2022-2025 | 91 | 1 |
